ASSOCIATION OF THYROID AUTOIMMUNITY WITH POST COVID-19 TELOGEN EFFLUVIUM IN FEMALES: A CASE CONTROL STUDY
Genetics and Molecular Research · 27.10.2026
DOI: 10.4238/3z4dgs34 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 27.10.2026. Verfasst von Dindar Sharif Qurtas. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Introduction
Telogen effluvium is a common cause of diffuse hair loss following systemic stress. There were many reports documented post-COVID-19-telogen effluvium. Thyroid hormones have important role in the hair follicle cycle. In this study we investigated thyroid hormones profile including thyroid autoantibodies in cases of post-COVID-19-telogen effluvium Aims: To evaluate the association between thyroid function, autoimmune markers, and post-COVID-19 telogen effluvium in females. Settings and Design: A case–control study was conducted in Erbil Dermatology Teaching Center, Kurdistan Region, Iraq. Methods and Material: Study conducted including 107 female patients with post-COVID-19 telogen effluvium and 99 age matched controls without hair loss. Thyroid profile parameters (free T3, Free T4, TSH, Anti-TPO, Anti-Tg) obtained from the patients and control group subjects. Statistical analysis used: Means of the thyroid parameters been calculated from both groups and compared. Multivariate logistic regression and ROC curve analysis were performed.
Results
Patients with hair loss had significantly higher levels of fT4, TSH, and Anti-TPO antibody (p < 0.001). Anti-TPO was the only independent predictor (OR = 1.06, 95% CI: 1.03–1.08). ROC analysis demonstrated excellent diagnostic performance of Anti-TPO antibody (AUC = 0.943) with an optimal cutoff of 7 IU/mL.
Conclusions
Post-COVID-19 telogen effluvium is strongly associated with thyroid autoimmunity. Anti-TPO is a valuable predictive biomarker and should be considered in the evaluation of affected patients.
Zitieren
APA
Qurtas, D. S. (2026). ASSOCIATION OF THYROID AUTOIMMUNITY WITH POST COVID-19 TELOGEN EFFLUVIUM IN FEMALES: A CASE CONTROL STUDY. Genetics and Molecular Research. https://doi.org/10.4238/3z4dgs34
Vancouver
Qurtas DS. ASSOCIATION OF THYROID AUTOIMMUNITY WITH POST COVID-19 TELOGEN EFFLUVIUM IN FEMALES: A CASE CONTROL STUDY. Genetics and Molecular Research. 2026. doi:10.4238/3z4dgs34
BibTeX
@article{Qurtas2026,
author = {Qurtas, Dindar Sharif},
title = {ASSOCIATION OF THYROID AUTOIMMUNITY WITH POST COVID-19 TELOGEN EFFLUVIUM IN FEMALES: A CASE CONTROL STUDY},
journal = {Genetics and Molecular Research},
year = {2026},
doi = {10.4238/3z4dgs34}
}
EUVIMED